Connable Office Inc. cut its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 3.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,208 shares of the medical research company’s stock after selling 761 shares during the quarter. Thermo Fisher Scientific comprises approximately 0.8% of Connable Office Inc.’s holdings, making the stock its 21st biggest position. Connable Office Inc.’s holdings in Thermo Fisher Scientific were worth $3,700,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. BB&T Securities LLC grew its stake in shares of Thermo Fisher Scientific by 4.4% in the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after buying an additional 3,819 shares in the last quarter. Toronto Dominion Bank grew its stake in shares of Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after buying an additional 37,307 shares in the last quarter. IBM Retirement Fund grew its stake in shares of Thermo Fisher Scientific by 117.7% in the second quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock valued at $1,860,000 after buying an additional 5,157 shares in the last quarter. Cornerstone Investment Partners LLC grew its stake in shares of Thermo Fisher Scientific by 41.7% in the second quarter. Cornerstone Investment Partners LLC now owns 421,541 shares of the medical research company’s stock valued at $73,546,000 after buying an additional 123,954 shares in the last quarter. Finally, Mitchell Capital Management Co. grew its stake in shares of Thermo Fisher Scientific by 40.3% in the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after buying an additional 12,910 shares in the last quarter. 83.36% of the stock is owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 191.86 on Tuesday. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30. The firm has a market cap of $74.85 billion, a P/E ratio of 33.43 and a beta of 1.05. The stock’s 50 day moving average price is $180.67 and its 200-day moving average price is $170.94.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.03. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.03 EPS. On average, analysts predict that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

TMO has been the subject of several analyst reports. Bank of America Corporation reissued a “buy” rating and issued a $210.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Citigroup Inc. reissued a “buy” rating and issued a $201.00 target price (up from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. BidaskClub cut shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Finally, Deutsche Bank AG set a $200.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Saturday, June 10th. Two investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $193.56.

COPYRIGHT VIOLATION WARNING: “Connable Office Inc. Has $3.70 Million Position in Thermo Fisher Scientific Inc (TMO)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/09/19/connable-office-inc-has-3-70-million-position-in-thermo-fisher-scientific-inc-tmo.html.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the sale, the vice president now owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director C Martin Harris sold 360 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The disclosure for this sale can be found here. Insiders have sold a total of 22,738 shares of company stock worth $4,021,512 in the last three months. 0.49% of the stock is currently owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.